BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27174866)

  • 21. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
    Keramida G; Hunter J; Dizdarevic S; Peters AM
    Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of image reconstruction settings on 18F-FDG PET radiomic features: multi-scanner phantom and patient studies.
    Shiri I; Rahmim A; Ghaffarian P; Geramifar P; Abdollahi H; Bitarafan-Rajabi A
    Eur Radiol; 2017 Nov; 27(11):4498-4509. PubMed ID: 28567548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative radiomics: Validating image textural features for oncological PET in lung cancer.
    Yang F; Young LA; Johnson PB
    Radiother Oncol; 2018 Nov; 129(2):209-217. PubMed ID: 30279049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining a radiotherapy target with positron emission tomography.
    Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a nomogram combining clinical staging with (18)F-FDG PET/CT image features in non-small-cell lung cancer stage I-III.
    Desseroit MC; Visvikis D; Tixier F; Majdoub M; Perdrisot R; Guillevin R; Cheze Le Rest C; Hatt M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1477-85. PubMed ID: 26896298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
    Groheux D; Majdoub M; Tixier F; Le Rest CC; Martineau A; Merlet P; Espié M; de Roquancourt A; Hindié E; Hatt M; Visvikis D
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1682-1691. PubMed ID: 26140849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
    Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
    J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.
    Dong X; Xing L; Wu P; Fu Z; Wan H; Li D; Yin Y; Sun X; Yu J
    Nucl Med Commun; 2013 Jan; 34(1):40-6. PubMed ID: 23111378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting the Recurrence of Gastric Cancer Using the Textural Features of Perigastric Adipose Tissue on [
    Ahn H; Song GJ; Jang SH; Son MW; Lee HJ; Lee MS; Lee JH; Oh MH; Jeong GC; Yun JH; Lee SM; Lee JW
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of pretreatment
    Chen SW; Shen WC; Lin YC; Chen RY; Hsieh TC; Yen KY; Kao CH
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):567-580. PubMed ID: 27999896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimized Feature Extraction for Radiomics Analysis of
    Papp L; Rausch I; Grahovac M; Hacker M; Beyer T
    J Nucl Med; 2019 Jun; 60(6):864-872. PubMed ID: 30389820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alterations in positron emission tomography imaging parameters on radiomics features.
    Ger RB; Meier JG; Pahlka RB; Gay S; Mumme R; Fuller CD; Li H; Howell RM; Layman RR; Stafford RJ; Zhou S; Mawlawi O; Court LE
    PLoS One; 2019; 14(9):e0221877. PubMed ID: 31487307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
    Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
    Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body
    Yamashita S; Yamamoto H; Nakaichi T; Yoneyama T; Yokoyama K
    Ann Nucl Med; 2017 Nov; 31(9):686-695. PubMed ID: 28815414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.